Palisade Bio Inc. (PALI) Misses Q3 EPS by 232c

Palisade Bio Inc. (NASDAQ: PALI) reported Q3 EPS of ($2.32).

For earnings history and earnings-related data on Palisade Bio Inc. (PALI) click here.

You May Also Be Interested In

• Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Lyntris opens at $15.50, below IPO price of $17.50